Updates from Canadian Association for Study of Liver. Our members care for Canadians with #liverdisease and promote #liverhealth with research & education.

Canada
Joined April 2012
This @CanLivJ #AdvanceAccess paper explores how altering gut bacteria and metabolism, through treatments like lactulose, antibiotics, and bowel cleansing, may reduce ammonia production and improve confusional states in advanced liver disease: bit.ly/CanLivJAA1 @CASLupdates
2
2
52
Had a great time at @_ILTS_ 🔑We found: 2002-2024 (UNOS), public insurance = associated w/⬆️ mortality across all regions even when accounting for policy era changes 🔑MASLD pts may be most at risk 🔑@leandrosierraca is a 🌟 ❤️thx to 🇨🇦/texas new/old friends for including me!
2
1
28
3,136
🚨Proud of our new publication in @HEP_Journal🚨 FIB-4 misses 36% of significant #fibrosis in #HIV (n≈5,000, 7 centers) — worse in #MASLD. 💡 FIB-4 alone isn’t enough. ➡️ Add metabolic + HIV factors (FIB-HIV) ➡️ Consider earlier transient elastography journals.lww.com/hep/abstrac…
1
19
2
44
2,543
Save your spot now for the Advancing Diversity, Equity & Inclusion in Transplantation 2025 in Toronto! Earn 9.5 credit hours. Join us on Oct 25 - 26, 2025. 🔗 vist.ly/4atg9 #ADEIT2025 #Diversity #Equity #Inclusion #Transplantation #MedicalConference #TorontoEvents
1
119
🎤Honoured to present at the #SLD Middle East School of #Hepatology in #Cairo 🇪🇬—co-organized by #EASL, #UCHID, #SASLT & #ESMA. 🌟 Stellar program & faculty. Shared updates on SLD in special populations (#IBD). 🙏 Thanks to all—let’s keep the momentum!🌍 #MASLD #EASL #MiddleEast
1
1
3
792
📢 New publication alert! Our review explores the interplay between #HIV, #LiverDisease & #VitaminD. 🌞 Deficiency is common 🧬 Links to fibrosis plausible 📈 More studies needed 👉onlinelibrary.wiley.com/doi/… #MASLD #HCV #HBV #hepatology #LiverHealth #WomenInMedicine #OpenAccess
2
9
661
🎉 Excited to celebrate the first impact factor of the Canadian Liver Journal! 📖 The voice of #CASL & Canadian #hepatology 🌍 Open access, global reach 👉 Submit your next paper to the Canadian Liver Journal & join us in advancing #liver health! 🔗 doi.org/10.3138/canlivj-2025…
1
1
6
959
🚨Honoured and grateful!🚨 Thrilled to receive the 2025 Montreal General Hospital Research Awards, recognizing my work on fatty #liver in people with inflammatory #bowel disease. 🙏 Deeply thankful to the Fondation de l'Hôpital général de Montréal and its benefactors. #MASLD #IBD
3
18
786
📢New paper out! In people with #HIV, severity of #MASLD is linked to a distinct gut #microbiota signature 🦠—but not functional pathway shifts. 🎯Microbial profiling could complement #noninvasive risk stratification for #liver disease in this group. 🔗mdpi.com/1422-0067/26/17/816…
1
2
7
702
🎉Exciting news!!🎉 🎯Our study on the high burden of #liver fibrosis in people with #HIV screened for #steatosis was selected for oral presentation at #AASLD2025 in Washington D.C.!🇺🇸 👏Huge thanks to our amazing team for advancing equity in liver health and HIV! #MASLD #TLM2025
1
3
18
1,044
🧬The latest meta-analysis on fatty #liver prevalence in HIV included 5 studies from our team! ✳️A testament to our deep involvement in this critical field. ➡️People with #HIV are a vulnerable population for #MASLD, with prevalence at 38%.🩺 👉DOI: 10.1186/s12879-025-10455-y
4
13
880
The majority of the world's #MASLD patient population remain undiagnosed. In CanLivJ 8.2, learn about whether the clinical and biochemical features of undiagnosed individuals resemble those with an established diagnosis of MASLD: bit.ly/CanLivJ82l @umanitoba @CASLupdates
1
79
A new study in Canadian Liver Journal 8.2 aims to describe the receptivity of cirrhosis patients to technology-based nutrition education. Explore the article today: bit.ly/CanLivJ82k @CRCHUM @UMontreal #Cirrhosis #Liver #HealthCare #Technology @CASLupdates @AMMICanada
1
97
Cirrhosiscare.ca is an expert consensus-based online palliative care resource for #HealthCare providers. Discover how this platform aims to improve symptom burden for #cirrhosis patients in the CanLivJ 8.2: bit.ly/CanLivJ82f @UAlberta @CirrhosisCareAB @CASLupdates
1
109
Drug poisoning is a public health crisis, particularly among people living with #HIV and #HCV. In the new issue of CanLivJ, scholars from @McGillU ask whether identifying predictors of drug poisoning could help decrease drug-related deaths: bit.ly/CanLiv82j @CASLupdates
1
82
The majority of the world's #MASLD patient population remain undiagnosed. In CanLivJ 8.2, learn about whether the clinical and biochemical features of undiagnosed individuals resemble those with an established diagnosis of MASLD: bit.ly/CanLivJ82l @umanitoba @CASLupdates
1
84
Replying to @liver4kids
Honoured to coauthor this work with MASLD experts. We must prioritize pediatric MASLD to improve care and awareness. Addressing this in kids is key to halting the epidemic. @CASLupdates @FattyLiverA @CanMASLDNetwork @NASPGHAN @AASLDtweets
2
3
159
#FoodIsMedicine! Thanks for featuring me in your article, Marisa! ✅Essential connection between food, liver health, and chronic disease prevention ✅Access to healthy food is key🍎🥦 👉glebereport.ca/articles/whol… @RIMUHC1 @CanMASLDNetwork @CASLupdates #communautéFRQ #MASLD @mcgillu
1
2
163
Drug poisoning is a public health crisis, particularly among people living with #HIV and #HCV. In the new issue of CanLivJ, scholars from @McGillU ask whether identifying predictors of drug poisoning could help decrease drug-related deaths: bit.ly/CanLiv82j @CASLupdates
1
1
89
A new study in Canadian Liver Journal 8.2 aims to describe the receptivity of cirrhosis patients to technology-based nutrition education. Explore the article today: bit.ly/CanLivJ82k @CRCHUM @UMontreal #Cirrhosis #Liver #HealthCare #Technology @CASLupdates @AMMICanada
1
1
74